Nanotechnology has emerged as a transformative force in oncology, facilitating
advancements in site-specific cancer therapy and personalized oncomedicine. The …

Nanomedicine is a promising strategy for improving clinical outcomes for cancer therapies,
by improving drug efficacy through enhanced delivery to disease sites. It is of importance for …

Advancements in our understanding of the complex process of tumorigenesis have
uncovered the many challenges faced by current systemic therapeutic options for the …

Cancer has become the leading cause of death among different populations of the world.
The treatment is limited to chemotherapy, radiation, and surgery. Selective targeting to the …

Cancer continues to be a prevalent and lethal disease, despite advances in tumor biology
research and chemotherapy development. Major obstacles in cancer treatment arise from …

Nanotechnology provides a variety of nanoscale tools for medicine. Among them
nanoparticles are revolutionizing the field of drug delivery. These drug nanocarriers have …

The ability to efficiently deliver a drug or gene to a tumor site is dependent on a wide range
of factors including circulation time, interactions with the mononuclear phagocyte system …

Nanotechnology has brought about the advent of personalized medicine in the era of
targeted therapeutic strategies for cancer therapy. The ability to exploit tumor features for …

Nanoparticle approaches to drug delivery for cancer offer exciting and potentially “game-
changing” ways to improve patient care and quality of life in numerous ways, such as …

The encapsulation of targeting agents into nanoscale drug delivery systems (DDS) for
cancer therapy has received considerable attention in recent years. The thriving area of …